Drug profile

The FDA adverse-event record for Progesterone

526 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Progesterone. See the species affected, top reactions, and outcomes below.

526
adverse-event reports
4.2%
death-coded share
Cattle
most-reported species
116
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
526
Total Reports
22
Deaths Reported
4.2%
Death Rate

Active Ingredients

Progesterone

Administration Routes

VaginalUnknownTopicalOralIntramuscularIntrauterine

Species Affected

Cattle 252
Unknown 209
Sheep 28
Goat 16
Human 11
Dog 4
Horse 4
White tailed deer 2

Most Affected Breeds

Unknown 222
Mixed (Cattle) 97
Aberdeen Angus 66
Cattle (other) 26
Hereford cattle 13
Cattle (unspecified) 12
Cattle (unknown) 10
Sheep (unknown) 10
Holstein-Friesian also known as Holstein 7
Boer 7

Most Reported Reactions

Lack of efficacy - NOS 116
INEFFECTIVE, ESTRUS SYNCHRONIZ 93
Insert, Damaged 60
Containers, Damaged 40
Insert, Abnormal 36
Product Defect, General 29
Rectal prolapse 29
Device Defective NOS 27
Uncoded sign 27
Underfilling, Package 23
Tablets, Abnormal 23
No sign 22

Outcome Breakdown

Outcome Unknown
237 (80.1%)
Recovered/Normal
32 (10.8%)
Died
20 (6.8%)
Ongoing
5 (1.7%)
Euthanized
2 (0.7%)

Progesterone Adverse Event Insights

526 reports name Progesterone; 22 recorded a death outcome (4.2% of reported events, not a population-level mortality rate). Active ingredient: Progesterone. Administration routes: Vaginal, Unknown, Topical, Oral.

By species: Cattle (252 reports), Unknown (209 reports), Sheep (28 reports). By breed: Unknown (222), Mixed (Cattle) (97), Aberdeen Angus (66).

Leading clinical signs: Lack of efficacy - NOS (116), INEFFECTIVE, ESTRUS SYNCHRONIZ (93), Insert, Damaged (60), Containers, Damaged (40). Outcome, 296 coded reports: Outcome Unknown leads at 80.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.